These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 19517457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.
    Hawkins DS, Rajendran JG, Conrad EU, Bruckner JD, Eary JF.
    Cancer; 2002 Jun 15; 94(12):3277-84. PubMed ID: 12115361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.
    Kong CB, Byun BH, Lim I, Choi CW, Lim SM, Song WS, Cho WH, Jeon DG, Koh JS, Yoo JY, Lee SY.
    Eur J Nucl Med Mol Imaging; 2013 May 15; 40(5):728-36. PubMed ID: 23361860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
    Bajpai J, Kumar R, Sreenivas V, Sharma MC, Khan SA, Rastogi S, Malhotra A, Gamnagatti S, Kumar R, Safaya R, Bakhshi S.
    J Pediatr Hematol Oncol; 2011 Oct 15; 33(7):e271-8. PubMed ID: 22193290
    [Abstract] [Full Text] [Related]

  • 9. Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.
    Byun BH, Kim SH, Lim SM, Lim I, Kong CB, Song WS, Cho WH, Jeon DG, Lee SY, Koh JS, Chung SK.
    Eur Radiol; 2015 Jul 15; 25(7):2015-24. PubMed ID: 25680716
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
    Hamada K, Tomita Y, Inoue A, Fujimoto T, Hashimoto N, Myoui A, Yoshikawa H, Hatazawa J.
    Ann Nucl Med; 2009 Jan 15; 23(1):89-95. PubMed ID: 19205843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience.
    Kim DH, Kim SY, Lee HJ, Song BS, Kim DH, Cho JB, Lim JS, Lee JA.
    Cancer Res Treat; 2011 Sep 15; 43(3):170-5. PubMed ID: 22022294
    [Abstract] [Full Text] [Related]

  • 14. Can pretreatment 18F-FDG PET tumor texture features predict the outcomes of osteosarcoma treated by neoadjuvant chemotherapy?
    Song H, Jiao Y, Wei W, Ren X, Shen C, Qiu Z, Yang Q, Wang Q, Luo QY.
    Eur Radiol; 2019 Jul 15; 29(7):3945-3954. PubMed ID: 30859285
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
    Dutour A, Decouvelaere AV, Monteil J, Duclos ME, Roualdes O, Rousseau R, Marec-Bérard P.
    J Nucl Med; 2009 Sep 15; 50(9):1533-40. PubMed ID: 19690032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.